Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 9, 2011, Pages

  Kramann, Rafael ^a   Couson, Simone K ^b   Neuss, Sabine ^b,c   Kunter, Uta ^a   Bovi, Manfred ^d   Bornemann, Jörg ^d   Knüchel, Ruth ^b   Jahnen Dechent, Willi ^c   Floege, Jürgen ^a   Schneider, Rebekka K ^b  

^a Department of Nephrology and Clinical Immunology ^*  (Colombia)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c Institute for Biomedical Engineering   (Germany)

^d RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

apoptosis; calcification; matrix; vascular biology

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; COLLAGEN TYPE 1; COLLAGEN TYPE 3; NOGGIN; OSTEOPONTIN; TRANSCRIPTION FACTOR RUNX2;

APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CALCIFICATION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UREMIA;

ADULT; AGED; APOPTOSIS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CALCINOSIS; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; MYOFIBROBLASTS; OSTEOGENESIS; PHENOTYPE; UREMIA;

EID: 80052153709     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.228601     Document Type: Article

References (53)

1. Shao JS, Cai J , Towler DA. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol. 2006;26:1423-1430. (Pubitemid 44288965)
2. Demer LL. A skeleton in the atherosclerosis closet. Circulation. 1995; 92:2029-2032.
3. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993;91:1800-1809. (Pubitemid 23127387)
4. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res. 2006;99: 1044-1059. (Pubitemid 44729928)
5. Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol. 2010;7:528-536.
6. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Bostrom K, Demer LL. Multilineage potential of cells from the artery wall. Circulation. 2003;108:2505-2510. (Pubitemid 37444413)
7. Abedin M, Tintut Y, Demer LL. Mesenchymal stem cells and the artery wall. Circ Res. 2004;95:671-676. (Pubitemid 39331926)
8. Collett GD, Canfield AE. Angiogenesis and pericytes in the initiation of ectopic calcification. Circ Res. 2005;96:930-938. (Pubitemid 40712792)
9. Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol. 2009;217:318-324.
10. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, Fries JW, Tiemann K, Bohlen H, Hescheler J, Welz A, Bloch W, Jacobsen SE, Fleischmann BK. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 2007;110:1362-1369. (Pubitemid 47281438)
11. Kunter U, Rong S, Boor P, Eitner F, Muller-Newen G, Djuric Z, van Roeyen CR, Konieczny A, Ostendorf T, Villa L, Milovanceva-Popovska M, Kerjaschki D, Floege J. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol. 2007;18:1754-1764. (Pubitemid 46870312)
12. Hruska KA, Mathew S, Lund RJ, Memon I, Saab G. The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature. Semin Nephrol. 2009;29:156-165.
13. Ketteler M, Schlieper G, Floege J. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension. 2006;47: 1027-1034. (Pubitemid 44289155)
14. Qunibi WY. Reducing the burden of cardiovascular calcification in patients with chronic kidney disease. J Am Soc Nephrol. 2005;16(Suppl 2):S95-S102. (Pubitemid 46173246)
15. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 2004;286: E686-E696. (Pubitemid 38506938)
16. Zitman-Gal T, Green J, Pasmanik-Chor M, Oron-Karni V, Bernheim J. Endothelial pro-atherosclerotic response to extracellular diabetic-like environment: possible role of thioredoxin-interacting protein. Nephrol Dial Transplant. 2010;25:2141-2149.
17. Shroff RC, McNair R, Skepper JN, Figg N, Schurgers LJ, Deanfield J, Rees L, Shanahan CM. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol. 2010;21:103-112.
18. Shimizu H, Hirose Y, Nishijima F, Tsubakihara Y, Miyazaki H. ROS and PDGF-beta [corrected] receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration. Am J Physiol Cell Physiol. 2009;297:C389-C396.
19. Serradell M, Diaz-Ricart M, Cases A, Petriz J, Ordinas A, Escolar G. Uraemic medium accelerates proliferation but does not induce apoptosis of endothelial cells in culture. Nephrol Dial Transplant. 2003;18:1079-1085. (Pubitemid 36722507)
20. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 2000;87:1055-1062.
21. Pai AS, Giachelli CM. Matrix remodeling in vascular calcification associated with chronic kidney disease. J Am Soc Nephrol. 2010;21: 1637-1640.
22. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2008;19:213-216. (Pubitemid 351240642)
23. Ergun S, Tilki D, Klein D. Vascular wall as a reservoir for different types of stem and progenitor cells. Antioxid Redox Signal. 2011 [Epub ahead of print].
24. Li S, Van Den Diepstraten C, D'Souza SJ, Chan BM, Pickering JG. Vascular smooth muscle cells orchestrate the assembly of type I collagen via alpha2beta1 integrin, RhoA, and fibronectin polymerization. Am J Pathol. 2003;163:1045-1056. (Pubitemid 37040140)
25. Jacob MP. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother. 2003;57:195-202. (Pubitemid 36897685)
26. Schneider RK, Puellen A, Kramann R, Raupach K, Bornemann J, Knuechel R, Perez-Bouza A, Neuss S. The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials. 2010;31:467-480.
27. Schneider RK, Neuss S, Stainforth R, Laddach N, Bovi M, Knuechel R, Perez-Bouza A. Three-dimensional epidermis-like growth of human mesenchymal stem cells on dermal equivalents: contribution to tissue organization by adaptation of myofibroblastic phenotype and function. Differentiation. 2008;76:156-167. (Pubitemid 351197177)
28. Schneider RK, Pullen A, Kramann R, Bornemann J, Knuchel R, Neuss S, Perez-Bouza A. Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents. Differentiation. 2010;79:182-193.
29. Neuss S, Becher E, Woltje M, Tietze L, Jahnen-Dechent W. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells. 2004;22:405-414. (Pubitemid 38736624)
30. Stark HJ, Szabowski A, Fusenig NE, Maas-Szabowski N. Organotypic cocultures as skin equivalents: a complex and sophisticated in vitro system. Biol Proced Online. 2004;6:55-60. (Pubitemid 38597693)
31. Schneider RK, Anraths J, Kramann R, Bornemann J, Bovi M, Knuchel R, Neuss S. The role of biomaterials in the direction of mesenchymal stem cell properties and extracellular matrix remodelling in dermal tissue engineering. Biomaterials . 2010;31:7948-79 59.
32. Chen D, Zhao M , Mundy GR. Bone morphogenetic proteins. Growth Factors. 2004;22:233-241. (Pubitemid 40136452)
33. Banerjee C, Javed A, Choi JY, Green J, Rosen V, van Wijnen AJ, Stein JL, Lian JB, Stein GS. Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology. 2001;142:4026-4039. (Pubitemid 32802676)
34. Prince M, Banerjee C, Javed A, Green J, Lian JB, Stein GS, Bodine PV, Komm BS. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem . 2001;80:424-4 40. (Pubitemid 32141498)
35. Abedin M, Tintut Y , Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol. 2004;24: 1161-1170. (Pubitemid 38880003)
36. Schneider RK, Neuss S, Knuchel R, Perez-Bouza A. [Mesenchymal stem cells for bone tissue engineering]. Pathologe. 2010; 31 (Suppl 2) :138-1 46.
37. Adiguzel E, Ahmad PJ, Franco C , Bendeck MP. Collagens in the progression and complications of atherosclerosis. Vasc Med. 2009;14:73-89.
38. Feaver RE, Gelfand BD, Wang C, Schwartz MA , Blackman BR. Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation. Circ Res. 2010; 106:1703-1711.
39. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-317. (Pubitemid 44269669)
40. Li J, Chai S, Tang C, Du J. Homocysteine potentiates calcification of cultured rat aortic smooth muscle cells. Life Sci. 2003;74:451-461. (Pubitemid 37377900)
41. Chen NX, O'Neill KD, Duan D, Moe SM. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int. 2002;62:1724-1731. (Pubitemid 35286280)
42. Chen NX, Duan D, O'Neill KD, Wolisi GO, Koczman JJ, Laclair R, Moe SM. The mechanisms of uremic serum-induced expression of bone matrix proteins in bovine vascular smooth muscle cells. Kidney Int. 2006;70: 1046-1053. (Pubitemid 44344074)
43. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan CM. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol. 2003;23:489-494. (Pubitemid 36337227)
44. Jono S, Nishizawa Y, Shioi A, Morii H. Parathyroid hormone-related peptide as a local regulator of vascular calcification: its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:1135-1142. (Pubitemid 27260334)
45. Jono S, Nishizawa Y, Shioi A, Morii H. 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation. 1998;98: 1302-1306. (Pubitemid 28443394)
46. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: a possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 1997;17:680-687. (Pubitemid 27169128)
47. Serradell M, Diaz-Ricart M, Cases A, Zurbano MJ, Aznar-Salatti J, Lopez-Pedret J, Ordinas A, Escolar G. Uremic medium disturbs the hemostatic balance of cultured human endothelial cells. Thromb Haemost. 2001;86:1099-1105. (Pubitemid 32975839)
48. Huysmans K, Lins RL, Daelemans R, Zachee P, De Broe ME. Hypertension and accelerated atherosclerosis in endstage renal disease. J Nephrol. 1998;11:185-195. (Pubitemid 28358072)
49. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int. 1997;51:1170-1181. (Pubitemid 27186543)
50. Bostrom K, Watson KE, Stanford WP, Demer LL. Atherosclerotic calcification: relation to developmental osteogenesis. Am J Cardiol. 1995; 75:88B-91B.
51. Murshed M, Harmey D, Millan JL, McKee MD, Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 2005;19: 1093-1104. (Pubitemid 40632454)
52. Watson KE, Parhami F, Shin V, Demer LL. Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory. Arterioscler Thromb Vasc Biol. 1998;18: 1964-1971. (Pubitemid 28565761)
53. Karsenty G. The complexities of skeletal biology. Nature. 2003;423: 316-318. (Pubitemid 40852704)